Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of moisturizers on skin barrier function in adults with atopic dermatitis history
2023-508560-29-00Phase 2Completed
- Sponsor
- ACO
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Miniderm, propylene glycol and Canoderm in atopic dermatitis (AD) (4 arms), sponsored by ACO. Primary endpoint: Transepidermal water loss comparison at Visits 3 and 5. Started Dec 2023; status: completed.
02
Drugs
Minidermpropylene glycolCanoderm
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2023-508560-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508560-29-00.